HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chungyee Leung-Hagesteijn Selected Research

GTx 134

7/2011Molecular target characterization and antimyeloma activity of the novel, insulin-like growth factor 1 receptor inhibitor, GTx-134.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chungyee Leung-Hagesteijn Research Topics

Disease

6Neoplasms (Cancer)
01/2022 - 11/2004
5Multiple Myeloma
01/2022 - 07/2011
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2011
1Sepsis (Septicemia)
03/2011
1Lymphocytosis
03/2011
1Breast Neoplasms (Breast Cancer)
11/2004
1Carcinoma (Carcinomatosis)
04/2004

Drug/Important Bio-Agent (IBA)

3Phosphotransferases (Kinase)IBA
12/2021 - 04/2004
2G-protein-coupled receptor kinase 6IBA
01/2022 - 12/2021
2Proteasome InhibitorsIBA
10/2015 - 09/2013
1Small Cytoplasmic RNAIBA
01/2022
1Insulin-Like PeptidesIBA
07/2011
1GTx 134IBA
07/2011
1Pharmaceutical PreparationsIBA
03/2011
1Lenalidomide (CC 5013)FDA Link
03/2011
1Messenger RNA (mRNA)IBA
11/2004
1integrin-linked kinaseIBA
11/2004
1Proteins (Proteins, Gene)FDA Link
11/2004
1Antigen-Antibody Complex (Immune Complex)IBA
04/2004

Therapy/Procedure

1Therapeutics
03/2011